Using Clinical Trial Simulators to Analyse the Sources of Variance in Clinical Trials of Novel Therapies for Acute Viral Infections.

MLA

Carolin Vegvari, et al. “Using Clinical Trial Simulators to Analyse the Sources of Variance in Clinical Trials of Novel Therapies for Acute Viral Infections.” PLoS ONE, vol. 11, no. 6, Jan. 2016, p. e0156622. EBSCOhost, https://doi.org/10.1371/journal.pone.0156622.

APA

Carolin Vegvari, Emilie Cauët, Christoforos Hadjichrysanthou, Emma Lawrence, Gerrit-Jan Weverling, Frank de Wolf, & Roy M Anderson. (2016). Using Clinical Trial Simulators to Analyse the Sources of Variance in Clinical Trials of Novel Therapies for Acute Viral Infections. PLoS ONE, 11(6), e0156622. https://doi.org/10.1371/journal.pone.0156622

Chicago

Carolin Vegvari, Emilie Cauët, Christoforos Hadjichrysanthou, Emma Lawrence, Gerrit-Jan Weverling, Frank de Wolf, and Roy M Anderson. 2016. “Using Clinical Trial Simulators to Analyse the Sources of Variance in Clinical Trials of Novel Therapies for Acute Viral Infections.” PLoS ONE 11 (6): e0156622. doi:10.1371/journal.pone.0156622.